141 related articles for article (PubMed ID: 37573475)
1. Enhancement of Microglia Functions by Developed Nano-Immuno-Synergist to Ameliorate Immunodeficiency for Malignant Glioma Treatment.
Xu M; Cheng Y; Meng R; Yang P; Chen J; Qiao Z; Wu J; Qian K; Li Y; Wang P; Zhou L; Wang T; Sheng D; Zhang Q
Adv Healthc Mater; 2023 Dec; 12(30):e2301861. PubMed ID: 37573475
[TBL] [Abstract][Full Text] [Related]
2. Interaction of tumor-associated microglia/macrophages and cancer stem cells in glioma.
Zhu X; Fang Y; Chen Y; Chen Y; Hong W; Wei W; Tu J
Life Sci; 2023 May; 320():121558. PubMed ID: 36889666
[TBL] [Abstract][Full Text] [Related]
3. Roles of purinergic P2X
McLarnon JG
Cancer Lett; 2017 Aug; 402():93-99. PubMed ID: 28536012
[TBL] [Abstract][Full Text] [Related]
4. Interaction of glioma-associated microglia/macrophages and anti-PD1 immunotherapy.
Wang C; Chen Q; Chen M; Guo S; Hou P; Zou Y; Wang J; He B; Zhang Q; Chen L; Luo L
Cancer Immunol Immunother; 2023 Jun; 72(6):1685-1698. PubMed ID: 36624155
[TBL] [Abstract][Full Text] [Related]
5. Glioma-associated microglial MMP9 expression is upregulated by TLR2 signaling and sensitive to minocycline.
Hu F; Ku MC; Markovic D; Dzaye O; Lehnardt S; Synowitz M; Wolf SA; Kettenmann H
Int J Cancer; 2014 Dec; 135(11):2569-78. PubMed ID: 24752463
[TBL] [Abstract][Full Text] [Related]
6. The controversial role of microglia in malignant gliomas.
Wei J; Gabrusiewicz K; Heimberger A
Clin Dev Immunol; 2013; 2013():285246. PubMed ID: 23983766
[TBL] [Abstract][Full Text] [Related]
7. CD38 deficiency in the tumor microenvironment attenuates glioma progression and modulates features of tumor-associated microglia/macrophages.
Levy A; Blacher E; Vaknine H; Lund FE; Stein R; Mayo L
Neuro Oncol; 2012 Aug; 14(8):1037-49. PubMed ID: 22700727
[TBL] [Abstract][Full Text] [Related]
8. A simple self-assembly nanomicelle based on brain tumor-targeting peptide-mediated siRNA delivery for glioma immunotherapy via intranasal administration.
Tang L; Zhang R; Wang Y; Zhang X; Yang Y; Zhao B; Yang L
Acta Biomater; 2023 Jan; 155():521-537. PubMed ID: 36384220
[TBL] [Abstract][Full Text] [Related]
9. Blocking NHE1 stimulates glioma tumor immunity by restoring OXPHOS function of myeloid cells.
Hasan MN; Luo L; Ding D; Song S; Bhuiyan MIH; Liu R; Foley LM; Guan X; Kohanbash G; Hitchens TK; Castro MG; Zhang Z; Sun D
Theranostics; 2021; 11(3):1295-1309. PubMed ID: 33391535
[No Abstract] [Full Text] [Related]
10. Glioma-associated microglia/macrophages (GAMs) in glioblastoma: Immune function in the tumor microenvironment and implications for immunotherapy.
Lin C; Wang N; Xu C
Front Immunol; 2023; 14():1123853. PubMed ID: 36969167
[TBL] [Abstract][Full Text] [Related]
11. Resident microglia rather than peripheral macrophages promote vascularization in brain tumors and are source of alternative pro-angiogenic factors.
Brandenburg S; Müller A; Turkowski K; Radev YT; Rot S; Schmidt C; Bungert AD; Acker G; Schorr A; Hippe A; Miller K; Heppner FL; Homey B; Vajkoczy P
Acta Neuropathol; 2016 Mar; 131(3):365-78. PubMed ID: 26718201
[TBL] [Abstract][Full Text] [Related]
12. Glioma Stem Cells but Not Bulk Glioma Cells Upregulate IL-6 Secretion in Microglia/Brain Macrophages via Toll-like Receptor 4 Signaling.
Dzaye O; Hu F; Derkow K; Haage V; Euskirchen P; Harms C; Lehnardt S; Synowitz M; Wolf SA; Kettenmann H
J Neuropathol Exp Neurol; 2016 May; 75(5):429-40. PubMed ID: 27030742
[TBL] [Abstract][Full Text] [Related]
13. When Immune Cells Turn Bad-Tumor-Associated Microglia/Macrophages in Glioma.
Roesch S; Rapp C; Dettling S; Herold-Mende C
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29389898
[TBL] [Abstract][Full Text] [Related]
14. Immune Checkpoint Targeted Therapy in Glioma: Status and Hopes.
Qi Y; Liu B; Sun Q; Xiong X; Chen Q
Front Immunol; 2020; 11():578877. PubMed ID: 33329549
[TBL] [Abstract][Full Text] [Related]
15. Microglia-glioma cross-talk: a two way approach to new strategies against glioma.
Arcuri C; Fioretti B; Bianchi R; Mecca C; Tubaro C; Beccari T; Franciolini F; Giambanco I; Donato R
Front Biosci (Landmark Ed); 2017 Jan; 22(2):268-309. PubMed ID: 27814616
[TBL] [Abstract][Full Text] [Related]
16. Microglia and macrophages in malignant gliomas: recent discoveries and implications for promising therapies.
da Fonseca AC; Badie B
Clin Dev Immunol; 2013; 2013():264124. PubMed ID: 23864876
[TBL] [Abstract][Full Text] [Related]
17. CD206 Expression in Induced Microglia-Like Cells From Peripheral Blood as a Surrogate Biomarker for the Specific Immune Microenvironment of Neurosurgical Diseases Including Glioma.
Tanaka S; Ohgidani M; Hata N; Inamine S; Sagata N; Shirouzu N; Mukae N; Suzuki SO; Hamasaki H; Hatae R; Sangatsuda Y; Fujioka Y; Takigawa K; Funakoshi Y; Iwaki T; Hosoi M; Iihara K; Mizoguchi M; Kato TA
Front Immunol; 2021; 12():670131. PubMed ID: 34267749
[TBL] [Abstract][Full Text] [Related]
18. Interactions between Tumor Cells, Neurons, and Microglia in the Glioma Microenvironment.
Radin DP; Tsirka SE
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33187183
[TBL] [Abstract][Full Text] [Related]
19. The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses.
Hussain SF; Yang D; Suki D; Aldape K; Grimm E; Heimberger AB
Neuro Oncol; 2006 Jul; 8(3):261-79. PubMed ID: 16775224
[TBL] [Abstract][Full Text] [Related]
20. Glioma-derived versican promotes tumor expansion via glioma-associated microglial/macrophages Toll-like receptor 2 signaling.
Hu F; Dzaye O; Hahn A; Yu Y; Scavetta RJ; Dittmar G; Kaczmarek AK; Dunning KR; Ricciardelli C; Rinnenthal JL; Heppner FL; Lehnardt S; Synowitz M; Wolf SA; Kettenmann H
Neuro Oncol; 2015 Feb; 17(2):200-10. PubMed ID: 25452390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
